Population of immunocompromised people who could be a candidate for a COVID-19 booster shot per the CDC. This would presumably apply to many people with MS taking DMTs such as b-cell depleters (ocrevus, rituximab, kesimpta), Lemtrada, S1P receptor modulators (gilenya, mayzent)